| VYNE Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the VYNE market cap history going back to 7/30/2020:
Also see: VYNE Shares Outstanding History and VYNE YTD Return |
VYNE Market Cap History — VYNE Therapeutics Capitalization Over Time
As of 5/1/2026 VYNE Therapeutics has a market cap of 21.38 million. Investors often follow the VYNE market cap history to compare the size of the company over time.
This page shows VYNE market capitalization trends over time, with 26 market cap datapoints presented, dating back to 7/30/2020.
| VYNE Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
VYNE Historical Market Cap: -35.84% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| VYNE Stock Price Chart |
| About VYNE Therapeutics Inc |
| VYNE Therapeutics Inc. is a biopharmaceutical company. Co. is focused on developing differentiated therapies for the treatment of immuno-inflammatory conditions. Its product candidate is VYN201, a locally administered pan-BET inhibitor designed as a soft drug to address diseases involving multiple, diverse inflammatory cell signaling pathways while providing low systemic exposure. Its second program is VYN202, a BD2-selective oral small molecule bromodomain and extra-terminal (BET) inhibitor in preclinical development for the treatment of immuno-inflammatory indications. We show 26 historical shares outstanding datapoints in our VYNE shares outstanding history coverage, used to compute VYNE market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing VYNE market cap history over the course of time is important for investors interested in comparing VYNE's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of VYNE versus a peer is one thing; comparing VYNE market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like VYNE can fluctuate over the course of history. With this page we aim to empower investors researching VYNE by allowing them to research the VYNE market cap history. |
| VYNE Current Stock Quote |
Quotes delayed 20 minutes  Free VYNE Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| VYNE Share Performance |
| Market Cap Peers |
| VYNE Therapeutics (VYNE) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
VYNT Market Cap History WAT Market Cap History WCG Market Cap History WGS Market Cap History WHWK Market Cap History WINT Market Cap History WMGI Market Cap History WST Market Cap History XAIR Market Cap History XBIO Market Cap History More Healthcare companies » |
VYNE Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
